Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

Open Vet J. 2023; 13(5): 668-676


Successful steroid tapering and partial treatment of suspected immune-mediated haemolytic anaemia in a dog with equine placenta extract supplementation: A case report

Sachiko Kotoku, Kentarou Tahara, Eiichi Hirano.




Abstract
Cited by 0 Articles

Background:
We report on the clinical management and outcome of an 11-year-old dog diagnosed with suspected refractory immune-mediated anaemia (IMHA) and treated with equine placental extract supplementation.
Case Description:
The patient had received standard treatment with subcutaneous infusion of prednisone (2 mg/kg) and oral administration (1.3 mg/kg semel in die [sid]), with limited success as haematocrit (HCT) values continued to fall rapidly, and the patient continued to have severe symptoms of fatigue. The patient was then put on equine placental extract supplements, after which the patient’s physical exhaustion was improved, and although the HCT level initially continued to fall, it eventually began to rise and remained near normal for approximately 2 years. Significant reduction in prednisone use was achieved with placental supplementation.
Conclusion:
Equine placental supplementation may be useful as a new complementary therapy for suspected refractory IMHA.

Key words: Suspected refractory immune-mediated anaemia, Steroid tapering, Partial treatment, Placenta extract supplementation, Case report






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.